Chronic effects of an endothelin-converting enzyme inhibitor on cardiorenal and hormonal function in heart failure

Clinical Science

Volumn 103, Issue SUPPL. 48, 2002, Pages

  Wada, Atsuyuki ^a   Ohnishi, Masato ^a   Tsutamoto, Takayoshi ^a   Fujii, Masanori ^a   Matsumoto, Takehiro ^a   Yamamoto, Takashi ^a   Wang, Xinwen ^a   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Hormone; Kidney; Sodium

Indexed keywords

5,6,8,13 TETRAHYDRO 1,6,9,14 TETRAHYDROXY 3 (2 HYDROXYPROPYL) 7 METHOXY 8,13 DIOXOBENZO[A]NAPHTHACENE 2 CARBOXYLIC ACID; ATRIAL NATRIURETIC FACTOR; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOG; FLUID BALANCE; FLUID RETENTION; GLOMERULUS FILTRATION RATE; HEART OUTPUT; HEART VENTRICLE CONTRACTION; HORMONE ACTION; LUNG CAPILLARY PRESSURE; NONHUMAN; PRIORITY JOURNAL; SODIUM URINE LEVEL; URINE FLOW RATE;

EID: 0036672077     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs103s254s     Document Type: Conference Paper

References (19)

1. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
2. Comparison of the effects of selective endothelin ETA and ETB receptor antagonists in congestive heart failure
3. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure
4. ET-1 in the myocardial interstitium: Relation to myocyte ECE activity and expression
5. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure. Comparison of effects with those of endothelin A receptor antagonism
6. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptides in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase coupled receptor
7. Short-term and long-term inhibition of endogenous atrial natriuretic peptide in dogs with early-stage heart failure
8. Endothelin-1 promotes vascular structural remodeling during the progression of heart failure: Prevention of vascular remodeling using a specific endothelin-converting enzyme inhibitor
9. Chronic effects of ANG II antagonist in heart failure: Improvement of cGMP generation from ANP
10. Endogenous atrial natriuretic peptide inhibits endothelin-1 secretion in dogs with severe congestive heart failure
11. Role of endogenous endothelin in chronic heart failure - Effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling
12. Expression and activity of pulmonary endothelin converting enzyme in heart failure: Relation to endothelin biosynthesis and receptor distribution
13. Regulation of aldosterone secretion in patients with chronic congestive heart failure by endothelins
14. Augmented expression of atrial natriuretic peptide gene in ventricle of human failing heart
15. The effect of spinolactone on morbidity and mortality in patients with severe heart failure
16. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure - Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
17. Endothelin: A potent renal and systemic vasoconstrictor peptide
18. Significant roles of endothelin-A- and -B-receptors in renal function in congestive heart failure
19. Comparison of the acute effects of a selective endothelin ETA and a mixed ETA/ETB receptor antagonist in heart failure